Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Target Price
The average target price of CTKB is 6.0 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell